最后审核时间： 六月 2019
最近更新时间： 二月 2019
小结
贡献者
作者 查看所有
Chief, Complex Chest Disease Center
Co-director, Interventional Pulmonology Massachusetts General Hospital
Harvard Medical School
Boston
MA
利益冲突披露
EEF is the global principal investigator for the NAVIGATE trial, sponsored by Medtronic. He has also served as scientific consultant for Boston Scientific in the development of advanced bronchoscopic techniques.
Director of Lung Cancer Program
Director of Lung Cancer Screening Program
Director of Education
Respiratory Institute
Cleveland Clinic
Cleveland
OH
利益冲突披露
PJM has been paid to participate in clinical advisory board meetings for Oncimmune, InDi, Nucleix, Grail, and Oncocytelooking, all companies interested in developing molecular biomarkers for the evaluation of lung nodules/ lung cancer; he does not have a contractual agreement to disseminate product information for any of these companies. PJM has participated in research supported by InDi Veracyte, that was paid to his institution. He has also participated in research with in-kind support from Oncimmune and 20/20 Genesystems.同行评议专家 查看所有
Consultant Physician
Royal Brompton Hospital
Chelsea & Westminster Hospital
London
UK
利益冲突披露
PLS declares that he has no competing interests.Associate Professor of Medicine
Medical Director
Lung Transplant Program
University of Chicago Hospitals
Chicago
IL
利益冲突披露
SMB declares that she has no competing interests.
使用此内容应接受我们的免责声明。
